We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+11.95%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$24.8B
AUM Growth
+$3.92B
(+19%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
7.15%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
613
New
70
Increased
229
Reduced
209
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$209M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$169M |
| 3 |
CVS Health
CVS
|
+$135M |
| 4 |
Conagra Brands
CAG
|
+$131M |
| 5 |
Ambev
ABEV
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$250M |
| 2 |
Transocean
RIG
|
+$168M |
| 3 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$133M |
| 4 |
Johnson & Johnson
JNJ
|
+$112M |
| 5 |
Capital One
COF
|
+$96.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.31% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.35% |
| 4 | Consumer Staples | 9.96% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.9T
| $544M | 2.19% |
14,521,850
+939,721
| +7% | +$34.1M |
|
2
New Oriental
EDU
$7.75B
| $500M | 2.02% |
15,887,063
+675,818
| +4% | +$18.8M |
|
3
Oracle
ORCL
$362B
| $455M | 1.83% |
11,885,612
+3,673,986
| +45% | +$126M |
|
|
ESRX
4
DELISTED
Express Scripts Holding Company
ESRX
| $454M | 1.83% |
6,469,832
+2,580,907
| +66% | +$169M |
|
5
US Bancorp
USB
$100B
| $394M | 1.59% |
9,751,671
+2,569,071
| +36% | +$98.5M |
|
|
6
CVS Health
CVS
$138B
| $393M | 1.58% |
5,486,553
+2,108,244
| +62% | +$135M |
|
7
Citigroup
C
$222B
| $388M | 1.56% |
7,455,215
+629,295
| +9% | +$31.8M |
|
8
Comcast
CMCSA
$84B
| $372M | 1.5% |
14,311,278
+5,208,272
| +57% | +$125M |
|
9
Amgen
AMGN
$198B
| $361M | 1.45% |
3,162,017
+624,943
| +25% | +$71.1M |
|
10
Alphabet (Google) Class C
GOOG
$4.17T
| $311M | 1.25% |
11,147,588
+1,655,301
| +17% | +$41.9M |
|
11
Cigna
CI
$75.4B
| $278M | 1.12% |
3,181,768
+1,008,045
| +46% | +$82.5M |
|
|
APC
12
DELISTED
Anadarko Petroleum
APC
| $277M | 1.12% |
3,497,575
+257,611
| +8% | +$23.1M |
|
13
Cisco
CSCO
$442B
| $270M | 1.09% |
12,045,402
-2,414,825
| -17% | -$53.4M |
|
14
Suncor Energy
SU
$76.4B
| $269M | 1.08% |
7,682,091
+1,512,648
| +25% | +$53.2M |
|
15
Morgan Stanley
MS
$343B
| $263M | 1.06% |
8,385,499
+1,820,663
| +28% | +$54.1M |
|
16
Omnicom Group
OMC
$22.6B
| $233M | 0.94% |
3,138,984
+1,168,842
| +59% | +$80.4M |
|
|
17
AbbVie
ABBV
$448B
| $230M | 0.92% |
4,349,664
+4,253,824
| +4,438% | +$209M |
|
|
18
Johnson & Johnson
JNJ
$615B
| $227M | 0.91% |
2,477,177
-1,211,470
| -33% | -$112M |
|
19
Apple
AAPL
$4.79T
| $222M | 0.89% |
11,074,672
+1,222,788
| +12% | +$23.1M |
|
20
Gilead Sciences
GILD
$162B
| $222M | 0.89% |
2,949,606
-25,349
| -0.9% | -$1.77M |
|
21
NetEase
NTES
$77.6B
| $219M | 0.88% |
13,949,840
+1,156,635
| +9% | +$16.2M |
|
|
NLSN
22
DELISTED
Nielsen Holdings plc
NLSN
| $216M | 0.87% |
4,704,278
+1,051,932
| +29% | +$43M |
|
23
Viatris
VTRS
$19.8B
| $215M | 0.87% |
4,959,502
+2,281,807
| +85% | +$93.8M |
|
|
MR
24
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $213M | 0.86% |
5,861,854
-224,516
| -4% | -$8.73M |
|
25
Intercontinental Exchange
ICE
$80.6B
| $211M | 0.85% |
4,698,560
+560,330
| +14% | +$23.1M |
|
Similar funds
Fidelity International's Q4 2013 Portfolio in Review
As of Q4 2013, Fidelity International held 613 positions worth $24.8B, up 19% from $20.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fidelity International deployed $1.77B of net new capital in Q4 2013, opening 70 new positions and adding to 229 existing holdings. Its largest new stake was Conagra Brands: 5,248,985 shares worth $138M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Merck, an estimated $250M trimmed.
- Fidelity International's largest Q4 2013 buy was Conagra Brands: 5,248,985 shares worth $138M.
- Fidelity International added most to AbbVie in Q4 2013, an estimated $209M increase.
- Fidelity International's biggest Q4 2013 reduction was Merck, cutting an estimated $250M.
- Fidelity International fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $133M.
- Fidelity International's ten largest holdings make up 20% of its $24.8B portfolio in Q4 2013.
- Fidelity International opened 70 new positions and closed 84 in Q4 2013.
- Fidelity International's portfolio value rose 19% quarter-over-quarter to $24.8B.
Based on Fidelity International's 13F filing for Q4 2013, filed 13 Feb 2014.